BD Ultra-Fine™ Pen Needles - HSA Registration DE0509025
Access comprehensive regulatory information for BD Ultra-Fine™ Pen Needles in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0509025 and owned by Becton, Dickinson and Company. The device was registered on March 05, 2024.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
BD Pen Needles are sterile, single-use devices intended for use with pen injectors for subcutaneous injection of drugs. Users may include caregivers, laypersons, and in countries where it is not precluded, health care professionals. The first and major application for BD pen needles is the subcutaneous administration of insulin and GLP-1 agonists for treatment of diabetes. The needles are also used to inject other medications for osteoporosis, fertility, rheumatoid arthritis, plaque psoriasis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis and plaque psoriasis and growth hormone